Benzinga | Aug 11, 2021 06:13AM EDT

Inozyme Pharma Q2 EPS $(0.53) Up From $(7.57) YoY

Inozyme Pharma (NASDAQ:INZY) reported quarterly losses of $(0.53) per share. This is a 93 percent increase over losses of $(7.57) per share from the same period last year.